Landiolol
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-[4-[(2S)-2-hydroxy-3-[2-(morpholine-4-carbonylamino)ethylamino]propoxy]phenyl]propanoate | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Routes | IV |
| Identifiers | |
| CAS number | 133242-30-5 |
| ATC code | None |
| PubChem | CID 114905 |
| UNII | 62NWQ924LH  |
| Chemical data | |
| Formula | C25H39N3O8 |
| Mol. mass | 509.59 g/mol |
| SMILES | eMolecules & PubChem |
 (what is this?) (verify) |
Landiolol (INN) is a drug which acts as a highly cardioselective, ultra short-acting beta blocker. It is used as an anti-arrhythmic agent.
[edit] References
- Yoshiya I (December 1998). "[Landiolol hydrochloride, a new sympathetic beta blocker]" (in Japanese). Masui 47 Suppl: S126–32. PMID 9921175.
- Ogata J, Okamoto T, Minami K (2003). "Landiolol for the treatment of tachyarrhythmia associated with atrial fibrillation". Can J Anaesth 50 (7): 753. doi:10.1007/BF03018726. PMID 12944459.
 |
This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |
